Reports Q3 revenue $3.98M vs. $3.35M last year. “Q3 2025 marks a critical milestone in VSEE‘s ascent as a telehealth leader, with revenue growth validating our focus on high-margin, AI-enhanced solutions that address clinician burnout and care access gaps,” said Dr. Milton Chen and Dr. Imo Aisiku, Co-CEO of VSEE Health (VSEE). “Our platform’s seamless integrations with EHR systems and remote monitoring tools are empowering hospitals to optimize workflows, while our telehealth care expertise is capturing a larger share of the $455 billion federal telehealth opportunity. Despite macroeconomic headwinds, our 70% reduction in operating cash use year-to-date demonstrates prudent execution. With a robust pipeline and FedRAMP unlocking government deals, we’re poised for profitability and exponential upside for our investors.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VSEE:
- VSee Health Enters Exchange and Stock Purchase Agreement
- VSee Health integrating advanced robotic assistance into ICUs
- VSee Health engages Philippine health leaders in Southeast Asia expansion effort
- VSee Health secures three-year platform services agreement
- VSee Health Enters Warrant Exchange Agreement